Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy
Anne Sophie V M van den Heerik, Nanda Horeweg, Stephanie M. de Boer, et al.
International Journal of Gynecological Cancer (2020) Vol. 31, Iss. 4, pp. 594-604
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Cancer of the corpus uteri: 2021 update
Martin Koskas, Frédéric Amant, Mansoor Raza Mirza, et al.
International Journal of Gynecology & Obstetrics (2021) Vol. 155, Iss. S1, pp. 45-60
Open Access | Times Cited: 233
Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality by Stage and Histologic Subtype
Megan A. Clarke, Susan S. Devesa, Anne Hammer, et al.
JAMA Oncology (2022) Vol. 8, Iss. 6, pp. 895-895
Open Access | Times Cited: 105
Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers: State of Art and Future Perspectives
Tullio Golia D’Augè, Andrea Giannini, Giorgio Bogani, et al.
Clinical and Experimental Obstetrics & Gynecology (2023) Vol. 50, Iss. 8
Open Access | Times Cited: 72
Endometrial Cancer: Transitioning from Histology to Genomics
Cristina Mitric, Marcus Q. Bernardini
Current Oncology (2022) Vol. 29, Iss. 2, pp. 741-757
Open Access | Times Cited: 40
Mechanism investigation and experiment validation of capsaicin on uterine corpus endometrial carcinoma
Zhiheng Lin, Xiaohui Sui, Wenjian Jiao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 39
Construction of a prognostic model of luteolin for endometrial carcinoma.
Junde Zhao, Wenjian Jiao, Xiaohui Sui, et al.
PubMed (2023) Vol. 15, Iss. 3, pp. 2122-2139
Closed Access | Times Cited: 30
The new 2023 FIGO staging system for endometrial cancer: what is different from the previous 2009 FIGO staging system?
Kyung Hee Han, Noh-Hyun Park, Maria Lee, et al.
Journal of Gynecologic Oncology (2024) Vol. 35, Iss. 5
Open Access | Times Cited: 14
Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment Changes
Maria-Bianca Anca-Stanciu, Andrei Manu, Maria Olincă, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1385-1385
Open Access | Times Cited: 1
Exploring the mechanism and experimental verification of puerarin in the treatment of endometrial carcinoma based on network pharmacology and bioinformatics analysis
Zhiheng Lin, Xiaohui Sui, Wenjian Jiao, et al.
BMC Complementary Medicine and Therapies (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 32
Optimizing Clinical Decision Making with Decision Curve Analysis: Insights for Clinical Investigators
Daniele Piovani, Rozeta Sokou, Andreas G. Tsantes, et al.
Healthcare (2023) Vol. 11, Iss. 16, pp. 2244-2244
Open Access | Times Cited: 21
SIR-EN—New Biomarker for Identifying Patients at Risk of Endometrial Carcinoma in Abnormal Uterine Bleeding at Menopause
Carlo Ronsini, Irene Iavarone, Maria Giovanna Vastarella, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3567-3567
Open Access | Times Cited: 7
Emerging Advances in Endometrial Cancer: Integration of Molecular Classification into Staging for Enhanced Prognostic Accuracy and Implications for Racial Disparities
Joy Ogunmuyiwa, Vonetta M. Williams
Cancers (2024) Vol. 16, Iss. 6, pp. 1172-1172
Open Access | Times Cited: 6
Endometrial Cancer in Pre-Menopausal Women and Younger: Risk Factors and Outcome
Nurliza Abdol Manap, Beng Kwang Ng, Su Ee Phon, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 15, pp. 9059-9059
Open Access | Times Cited: 26
Applications of FAPI PET/CT in the diagnosis and treatment of breast and the most common gynecologic malignancies: a literature review
Tengfei Li, Jintao Zhang, Yuanzhuo Yan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma
Antonella Ravaggi, Davide Capoferri, Laura Ardighieri, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5429-5429
Open Access | Times Cited: 20
A novel five-gene metabolism-related risk signature for predicting prognosis and immune infiltration in endometrial cancer: A TCGA data mining
Huaqing Huang, Xintong Cai, Jiexiang Lin, et al.
Computers in Biology and Medicine (2023) Vol. 155, pp. 106632-106632
Open Access | Times Cited: 13
Prognostic Value of the Cutoffs for HALP in Endometrial Cancer
Jinyu Wang, Peng Jiang, Yuzhen Huang, et al.
American Journal of Clinical Oncology (2023) Vol. 46, Iss. 3, pp. 107-113
Open Access | Times Cited: 12
Causes of death in endometrial cancer survivors: A Surveillance, Epidemiology, and End Result–based analysis
Qing Xue, Wenqiang Che, Lujiadai Xue, et al.
Cancer Medicine (2023) Vol. 12, Iss. 9, pp. 10917-10930
Open Access | Times Cited: 12
A Hypoxia Molecular Signature-Based Prognostic Model for Endometrial Cancer Patients
Yang Jiao, Rui Geng, Zihang Zhong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1675-1675
Open Access | Times Cited: 11
Pattern of recurrence in endometrial cancer. The murderer always returns to the scene of the crime
Vito Andrea Capozzi, Luciano Monfardini, Giuseppe Maglietta, et al.
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 3, pp. 107985-107985
Closed Access | Times Cited: 4
Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling
Yibin Lin, Xiaohong Chen, Linping Lin, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 4
Prediction of Lymph Node Metastasis in Endometrial Cancer Based on Color Doppler Ultrasound Radiomics
Xiaoling Liu, Weihan Xiao, Jing Qiao, et al.
Academic Radiology (2024) Vol. 31, Iss. 11, pp. 4499-4508
Closed Access | Times Cited: 4
The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside
Xin Sun, Yeting Hong, Yuhan Shu, et al.
Journal of Ginseng Research (2021) Vol. 46, Iss. 2, pp. 266-274
Open Access | Times Cited: 24
Endometrial microbiota from endometrial cancer and paired pericancer tissues in postmenopausal women: differences and clinical relevance
Lili Wang, Jiaolin Yang, Huancheng Su, et al.
Menopause The Journal of The North American Menopause Society (2022) Vol. 29, Iss. 10, pp. 1168-1175
Open Access | Times Cited: 18
Early recurrence after surgery in FIGO 2023 stage I-III endometrial cancer: characteristics and risk factors
Zhen Huang, Xue Li, Ling Li
Frontiers in Oncology (2025) Vol. 14
Open Access
Page 1 - Next Page

Scroll to top